Ixaltis
Developing innovative treatments for genitourinary tract disorders
Ixaltis has raised €11M across 2 funding rounds from 4 investors, most recently a Debt round in May 2016. Based in Archamps, France; active in Healthtech. Data as of 28 Oct 2026.
Archamps, Francewww.ixaltis.com ↗
Total raised
€11M
€10,800,000
Funding rounds
2
Investors
4
distinct backers
Active since
2016-05
latest 2016-05
Funding by year
EUR raised per yearIxaltis — funding by year — interactive chart.
Data table
| Ixaltis — funding by year | |
|---|---|
| 2016 | €11M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 10y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-05-01 | Debt | €2.8M | — | View deal → |
| 2016-05-01 | Series A | €8.0M | IRDInov,iXO Private Equity,Principia SGR,Sofimac Partners | View deal → |
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData